INS and type 2 diabetes mellitus: The key advantage of this non genetic model is that researchers can customize it to resemble the slow pathogenesis of T2D that occurs in most humans, encompassing the slow development from adult-onset DIO to glucose intolerance, IR, the resulting compensatory insulin release, and finally STZ-induced partial β-cell death.